Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Acquisition

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE · · 3 pages · English

Release

This is to inform you that the Board of Directors of the Company have at their meeting held today, i.e. 19/06/2025 approved to incorporate a Company as a wholly owned subsidiary in United States of America.

Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases